Skip to main content

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Marc Ribó Jacobi

Institutions of which they are part

Main researcher
Stroke research
Vall Hebron Institut de Recerca

Projects

Clinical trial to evaluate the administration of ApTOLL in ambulances and the neuroprotective effect in stroke patients. RACETOLL

IP: Marc Ribó Jacobi
Collaborators: Marta Aurora Rubiera Del Fueyo, Carlos Molina Cateriano, Federica Rizzo
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 437334
Reference: CPP2021-008378
Duration: 01/03/2022 - 28/02/2025

Ministerio de Ciencia

Development and validation of an artificial intelligence model for the prehospital management of patients with a suspected acute ischemic stroke

IP: Marc Ribó Jacobi
Collaborators: Alvaro Garcia Tornel Garcia Camba, Judit Álvarez González
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR22/00046
Duration: 01/01/2023 - 31/12/2026

ARTERIAL: un marco de IA para la planificación de operación a través de la caracterización automática de la tortuosidad vascular

IP: Marta Olive Gadea
Collaborators: Marc Ribó Jacobi
Funding agency: Instituto de Salud Carlos III
Funding: 107690
Reference: PI21/01967
Duration: 01/01/2022 - 31/12/2024

Flowcat: modelo de simulación neurovascular

IP: Marc Ribó Jacobi
Collaborators: Pere Canals Canals
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 89148.06
Reference: SLT017/20/000180
Duration: 22/07/2021 - 31/12/2024

Related news

UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.

The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.

Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.

Related professionals

Laura Sánchez Vela

Laura Sánchez Vela

Ophtalmology
Read more
Samuel Gonçalves Ribeiro

Samuel Gonçalves Ribeiro

Postdoctoral researcher
Read more
Elia Rojas Montserrat

Elia Rojas Montserrat

Administration and Management
Diabetes and Metabolism
Read more
María Díaz Hervás

María Díaz Hervás

Predoctoral researcher
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.